0000915913-19-000101.txt : 20191112 0000915913-19-000101.hdr.sgml : 20191112 20191112095441 ACCESSION NUMBER: 0000915913-19-000101 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191107 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barichivich John Clarence III CENTRAL INDEX KEY: 0001792555 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12658 FILM NUMBER: 191206755 MAIL ADDRESS: STREET 1: 4250 CONGRESS ST. STREET 2: SUITE 900 CITY: CHARLOTTE STATE: NC ZIP: 28209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBEMARLE CORP CENTRAL INDEX KEY: 0000915913 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 541692118 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4250 CONGRESS STREET STREET 2: SUITE 900 CITY: CHARLOTTE STATE: NC ZIP: 28209 BUSINESS PHONE: 980-299-5700 MAIL ADDRESS: STREET 1: 4250 CONGRESS STREET STREET 2: SUITE 900 CITY: CHARLOTTE STATE: NC ZIP: 28209 FORMER COMPANY: FORMER CONFORMED NAME: ECHEM INC DATE OF NAME CHANGE: 19931208 3 1 wf-form3_157357046526079.xml FORM 3 X0206 3 2019-11-07 0 0000915913 ALBEMARLE CORP ALB 0001792555 Barichivich John Clarence III ALBEMARLE CORPORATION 4250 CONGRESS STREET, SUITE 900 CHARLOTTE NC 28209 0 1 0 0 VP, Controller & CAO Common Stock 1891 D Common Stock 1187 I Albermarle Savings Plan Performance Unit 0.0 Common Stock 266.0 D Restricted Stock Unit 0.0 Common Stock 266.0 D Restricted Stock Unit 0.0 Common Stock 674.0 D Restricted Stock Unit 0.0 Common Stock 528.0 D Restricted Stock Unit 0.0 Common Stock 826.0 D Total number of shares of Common Stock held in the name of the Reporting Person under the Albemarle Corporation Retirement Savings Plan as of the date of this Form 3. Performance Units granted on 2/26/2016. First 50% vested on 2/26/2019 and second 50% vests on 2/26/2020. Each Performance Unit converts to 1 share of Common Stock. On 2/26/2016, the reporting person was granted 532 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2019 and 2020. First 50% vested on 2/26/2019 and second 50% vests on 2/26/2020. Each Restricted Stock Unit converts to 1 share of Common Stock. On 2/24/2017, the reporting person was granted 674 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2020 and 2021. First 50% will vest on 2/24/2020 and second 50% will vest on 2/24/2021. Each Restricted Stock Unit converts to 1 share of Common Stock. On 2/23/2018, the reporting person was granted 528 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2021 and 2022. First 50% will vest on 2/23/2021 and second 50% will vest on 2/23/2022. Each Restricted Stock Unit converts to 1 share of Common Stock. On 2/26/2019, the reporting person was granted 826 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2022 and 2023. First 50% will vest on 2/26/2022 and second 50% will vest on 2/26/2023. Each Restricted Stock Unit converts to 1 share of Common Stock. Exhibit List Exhibit 24 - Power of Attorney /s/ Brenda Mareski, attorney-in-fact 2019-11-12 EX-24 2 a2019powerofattorney-baric.htm EXHIBIT 24 Exhibit
Exhibit 24

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Karen G. Narwold, Stefanie M. Holland, Sarah E. Marshik and Brenda J. Mareski, or either of them acting singly and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

 
(1)
execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Albemarle Corporation (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;
 
(2)
do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
 
(3)
take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
 
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 28th day of October, 2019.



/s/ John C. Barichivich III        
             John C. Barichivich III